Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Ajellomyces dermatitidis Structure-specific endonuclease subunit SLX4 (SLX4), partial CSB-YP002843AZE
CSB-EP002843AZE
CSB-BP002843AZE
CSB-MP002843AZE
CSB-EP002843AZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida tropicalis Enolase-phosphatase E1 (UTR4) CSB-YP007674CZM
CSB-EP007674CZM
CSB-BP007674CZM
CSB-MP007674CZM
CSB-EP007674CZM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermococcus sibiricus Flap endonuclease 1 (fen) CSB-YP008585TMT
CSB-EP008585TMT
CSB-BP008585TMT
CSB-MP008585TMT
CSB-EP008585TMT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermococcus sibiricus Methylated-DNA--protein-cysteine methyltransferase (ogt) CSB-YP013788TMT
CSB-EP013788TMT
CSB-BP013788TMT
CSB-MP013788TMT
CSB-EP013788TMT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermococcus sibiricus FAD synthase (ribL) CSB-YP008710TMT
CSB-EP008710TMT
CSB-BP008710TMT
CSB-MP008710TMT
CSB-EP008710TMT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio salexigens ATP synthase subunit delta (atpH) CSB-YP002355DJQ
CSB-EP002355DJQ
CSB-BP002355DJQ
CSB-MP002355DJQ
CSB-EP002355DJQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio salexigens Elongation factor Ts (tsf) CSB-YP025124DJQ
CSB-EP025124DJQ
CSB-BP025124DJQ
CSB-MP025124DJQ
CSB-EP025124DJQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum Thymidylate synthase (thyA) CSB-YP025393ESQ
CSB-EP025393ESQ
CSB-BP025393ESQ
CSB-MP025393ESQ
CSB-EP025393ESQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum S-adenosylmethionine decarboxylase proenzyme (speD) CSB-YP001658ESQ
CSB-EP001658ESQ
CSB-BP001658ESQ
CSB-MP001658ESQ
CSB-EP001658ESQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum tRNA dimethylallyltransferase (miaA) CSB-YP024529ESQ
CSB-EP024529ESQ
CSB-BP024529ESQ
CSB-MP024529ESQ
CSB-EP024529ESQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum Translation initiation factor IF-3 (infC) CSB-YP015166ESQ
CSB-EP015166ESQ
CSB-BP015166ESQ
CSB-MP015166ESQ
CSB-EP015166ESQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum Cardiolipin synthase (cls), partial CSB-YP005985ESQ1
CSB-EP005985ESQ1
CSB-BP005985ESQ1
CSB-MP005985ESQ1
CSB-EP005985ESQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum Peptide chain release factor 1 (prfA) CSB-YP015197ESQ
CSB-EP015197ESQ
CSB-BP015197ESQ
CSB-MP015197ESQ
CSB-EP015197ESQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum Xaa-Pro dipeptidase (pepQ) CSB-YP017784ESQ
CSB-EP017784ESQ
CSB-BP017784ESQ
CSB-MP017784ESQ
CSB-EP017784ESQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum Argininosuccinate synthase (argG) CSB-YP002234ESQ
CSB-EP002234ESQ
CSB-BP002234ESQ
CSB-MP002234ESQ
CSB-EP002234ESQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum ATP synthase subunit beta (atpD) CSB-YP002350ESQ
CSB-EP002350ESQ
CSB-BP002350ESQ
CSB-MP002350ESQ
CSB-EP002350ESQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum N-acetyl-D-glucosamine kinase (nagK) CSB-YP015415ESQ
CSB-EP015415ESQ
CSB-BP015415ESQ
CSB-MP015415ESQ
CSB-EP015415ESQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter sp. Nucleoside diphosphate kinase (ndk) CSB-YP015889GFR
CSB-EP015889GFR
CSB-BP015889GFR
CSB-MP015889GFR
CSB-EP015889GFR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter sp. Elongation factor Ts (tsf) CSB-YP025124GFR
CSB-EP025124GFR
CSB-BP025124GFR
CSB-MP025124GFR
CSB-EP025124GFR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio G-protein coupled receptor 126 (gpr126), partial CSB-YP009747DIL
CSB-EP009747DIL
CSB-BP009747DIL
CSB-MP009747DIL
CSB-EP009747DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>